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Background: Attention Deficit/Hyperactivity Disorder (ADHD) is associated with an increased risk of co-existing
substance abuse. The Swedish legislation on compulsory healthcare can be applied to persons with severe
substance abuse who can be treated involuntarily during a period of six months. This context enables a reliable
clinical assessment of ADHD in individuals with severe substance use disorder (SUD).
Methods: In the context of compulsory care for individuals with severe SUD, male patients were assessed for
ADHD, co-morbid psychiatric symptoms, psychosocial background, treatment history, and cognition. The data from
the ADHD/SUD group (n = 60) was compared with data from (1) a group of individuals with severe substance abuse
without known ADHD (SUD group, n = 120), as well as (2) a group with ADHD from an outpatient psychiatric clinic
(ADHD/Psych group, n = 107).
Results: Compared to the general SUD group in compulsory care, the ADHD/SUD group had already been
significantly more often in compulsory care during childhood or adolescence, as well as imprisoned more often as
adults. The most common preferred abused substance in the ADHD/SUD group was stimulant drugs, while alcohol
and benzodiazepine abuse was more usual in the general SUD group. Compared to the ADHD/Psych group, the
ADHD/SUD group reported more ADHD symptoms during childhood and performed poorer on all tests of general
intellectual ability and executive functions.
Conclusions: The clinical characteristics of the ADHD/SUD group differed from those of both the SUD group
and the ADHD/Psych group in several respects, indicating that ADHD in combination with SUD is a particularly
disabling condition. The combination of severe substance abuse, poor general cognitive ability, severe psychosocial
problems, including indications of antisocial behaviour, and other co-existing psychiatric conditions should be
considered in treatment planning for adults with ADHD and SUD.
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Attention-Deficit/Hyperactivity Disorder (ADHD) is an
early-onset neurodevelopmental disorder characterized
by deficiencies in impulse control, regulation of activity
level, and attention. ADHD also frequently involves
executive dysfunctions, such as problems of planning,
organization, getting started, and completing activities.
While the prevalence of ADHD in the population is
about 1.2 – 7.3% [1], a recent meta-analysis estimated
the prevalence to be 19–27% in substance abusers,
depending on which preferred substance is studied [2].
A study in a high-security prison in Sweden estimated
the prevalence of adult ADHD among longer-term
inmates to be 40%, and the majority of clinically assessed
individuals with ADHD also had previous SUD [3]. Fur-
thermore, a 10-year follow-up study of children and ado-
lescents with ADHD found that the condition is a
significant predictor of any type of substance use disorder
(SUD) [4].
The increased risk for developing substance abuse
among individuals with ADHD may be related to the
core symptoms of ADHD, such as impulsivity, as well as
associated problems in ADHD, such as weakness in ex-
ecutive regulation of affects and motivation. Adults with
ADHD also report high levels of stress in everyday life
and poor coping ability [5] and substance abuse may be
a destructive coping strategy. Psychiatric co-morbidity is
common in clinically referred adults with ADHD. Eighty
% present with at least one additional DSM-IV diagnosis
[6-8] and co-morbidity as such may also increase the
risk of substance abuse. Furthermore, psychosocial fac-
tors such as failure in school and working life and expe-
riences of alienation among individuals with ADHD may
combine to increase the risk of substance abuse. A low
dopamine activity in persons with ADHD and the cap-
acity of all addictive substances to increase the release of
dopamine has been suggested to be a possible neural
link between ADHD and SUD [9,10].
The Law on Care of Alcoholics and Drug Abusers
(LVM) is one of four laws governing involuntary care in
Sweden. The National Board of Institutional Care (SiS)
is the authority responsible for compulsory treatment of
adults with severe substance abuse, according to the
LVM, as well as for compulsory care of children and ad-
olescents with severe social problems such as substance
abuse and antisocial behaviour, according to the law on
Care of Young Persons (LVU).
In Sweden, approximately 1000 individuals per year
are sentenced to compulsory care for severe substance
abuse in accordance with the LVM. There are more than
300 treatment sites that are distributed among 11 insti-
tutions around the country. In recent years, assessments
of neurodevelopmental disorders have frequently been
requested during the compulsory care under LVM. Inmany cases, it has not been possible to perform this type
of assessment due to an on-going substance abuse.
In the scientific literature, adults with ADHD have
been clinically characterized in psychiatric and forensic
[3] settings. However, to the best of our knowledge,
there are no studies describing the clinical characteristics
of adults with ADHD and severe substance abuse in
compulsory care.
The objective of the present study is a clinical charac-
terization of patients with ADHD and severe substance
abuse disorder in a compulsory care context. Our aim is
to increase the clinical understanding of this patient group
in order to facilitate adjustment of treatment for this clin-
ically challenging group. In order to characterize this
group, a comparison has been made with two other
groups: a group of patients with SUD in compulsory care
without a known ADHD and a group of individuals with
ADHD from a psychiatric outpatient setting.Methods
Study settings
The assessment of the study group was made between
the years 2004 and 2008 at an SiS institution, SiS LVM
Institution Hornö, located in Enköping, Sweden. The pa-
tient target of the SiS Institution Hornö is adult males
who, in addition to substance abuse, are violent and/or
may have other severe psychiatric co-morbidity. The pa-
tients come from different municipalities in Sweden and
have been placed at an institution of a central unit of the
National Board of Institutional Care. The SiS LVM Insti-
tution Hornö has conducted clinical assessments for
many years in order to obtain data for individualized
treatment planning, including treatment for ADHD. The
voluntary assessments are conducted when requested by
the patient’s social worker, the patient himself or the
ward staff.Participants
Figure 1 displays a flowchart describing the enrolment
of participants in the ADHD/SUD group. Between the
years 2004 and 2008, there were 413 individuals who
were treated at the SiS Institution Hornö. During this
period a total of 214 psychological assessments were
made with 71 patients being assessed for ADHD. The
participants in the ADHD/SUD group consist of 60 pa-
tients diagnosed with ADHD and recruited consecutively
from the SiS Institution Hornö. Thirteen of these 60 cli-
ents had received an ADHD diagnosis prior to the invol-
untary care at Hornö Institution. The mean age of the
participants was 26. 33 (SD = 6.07) years at admission to
the Institution and 27.08 (SD = 6.02) at the beginning of
the diagnostic assessment of ADHD (see below), with a
range of 20 to 46 years for both mean age figures.
Figure 1 Flowchart describing enrolment of participants in the
ADHD/SUD group from the SiS institution Hornö.
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compulsory care, we used two control groups. First, a
general SUD group in compulsory care without known
ADHD diagnosis and second, a group with ADHD with-
out severe SUD in voluntary outpatient psychiatric care
(ADHD/Psych group). Data for these control groups
were extracted as follow.
In order to compare the characteristics of the combined
ADHD/SUD group with the general SUD population in
involuntary care, we used unidentified data from the SiS
internal database (DOK, a SiS follow-up and documenta-
tion system), matched for age and years of assessment and
covering the majority of the treated patients. During the
time period for current study (2004–2008), a total of 1968
male clients were registered in DOK database. We se-
lected data on 120 male clients without known ADHD
diagnosis matched with the ADHD/SUD group from
Hornö Institution for age and year of admission.
For comparison of the ADHD/SUD group the SiS Insti-
tution from Hornö with individuals with ADHD in volun-
tary psychiatric outpatient care, we used data on patients
assessed at an outpatient tertiary psychiatric clinic, the
Neuropsychiatric Unit Karolinska, Psychiatry Northwest,
Stockholm, Sweden. The data on the ADHD/Psych group
were extracted from an anonymous database, and theinclusion/matching criteria were sex (males), age range
(19 to 46 years), and year of diagnostic assessment
(2004–2008). One hundred seven individuals met these
criteria and were all included in the ADHD/Psych group.
The ADHD/Psych group had a mean age of 29.6 years
(SD = 7.28) and were thus somewhat older than the
ADHD/SUD group (M =27.08, SD = 6.02). The difference
in age was statistically significant, as indicated by Student’s
t-test (p = .002).
Diagnoses of other neurodevelopmental disorders in
addition to ADHD were obtained from the patient’s
medical records. In addition to ADHD, 30.0% of the
ADHD/SUD group and 40.2% of the ADHD/Psych
group had a co-existing Asperger syndrome diagnosis or
other neurodevelopmental disorders (dyslexia, dyscalcu-
lia, developmental coordination disorder, Tourette syn-
drome, pervasive developmental disorder or mental
retardation).
None of the study groups (ADHD/SUD; general SUD;
ADHD/Psych) were originally recruited to a research
study but the assessments were performed as an ordin-
ary clinical work. Thus, the study had a retrospective de-
sign and the participants did not give their written
informed consents. The study was approved by the Re-
gional Ethics Committee of Stockholm (2009/823-31/4
and 42-790-2012).
Procedure
Assessment of background information
In compulsory care for SUD, interviews with the clients
are conducted on admission, discharge and one year
after discharge. The semi-structured interviews, which
are voluntary, are conducted by treatment staff at the
SiS institutions for compulsory treatment of severe SUD.
The data from the interviews are stored in the SiS evalu-
ation and documentation system, the DOK database,
which provides a large amount of information intended
to guide treatment planning, as well as to provide a basis
for research, operational planning, and follow-up.
Not all clients in the study group had had the DOK
interviews and, in these cases, the background data
were studied during the clinical ADHD assessment
(see below).
The assessment of the general SUD group without a
known ADHD (n = 120) was obtained entirely from an
anonymous database comprising all DOK-interviewed
clients.
Assessment of ADHD
The assessments at the SiS Institution Hornö began when
the clients were thoroughly detoxified, approximately two
months after the initiation of treatment. Regular drug
screening was general clinical practice throughout the
treatment period at the Hornö Institution. The diagnostic
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the institution and having solid professional experience in
the field of neurodevelopmental disorders. The assessment
was extensive, lasting approximately 20–25 hours in total
for each individual and was based on multiple sources of
information: a semi-structured clinical interview based on
the Diagnostic and Statistical Manual of Mental disorders-
Fourth Edition [11] was conducted in all cases. The clients
also completed standardized self-rating questionnaires
assessing childhood (WURS, Wender Utah Rating Scale)
as well as adult (Brown ADD scale) ADHD-symptoms.
When possible, collateral information (questionnaires and
clinical interviews) was gathered from the participants’ sig-
nificant others in order to obtain a more complete diagnos-
tic history of each individual. When available, additional
information was obtained from case files from child and
adolescent psychiatry, from institutions for involuntary care
during childhood and/or adolescence, as well as from adult
psychiatry settings. The assessments also included neuro-
psychological testing. The diagnosis of ADHD was estab-
lished after reaching a consensus between two or three
clinical psychologists from the SiS LVM Institution Hornö,
or between a psychologist from the institution and a con-
sulting specialist in neuropsychology.
The diagnostic assessment of the ADHD/Psych group
was made using similar procedures and methods, since
this type of extensive multiple data-source, consensus-
based diagnostic assessments were a standard in Sweden
during that time period.
Measures
The data in the comparisons of the ADHD/SUD group
and the general SUD group were obtained from the
evaluation and documentation system, DOK. In the
ADHD/SUD group, 22 out of 60 never had a DOK inter-
view and, in these cases, the data were obtained from
the clinical assessments made somewhat later during the
compulsory care period. The ADHD/SUD group was
compared with the general SUD in compulsory care re-
garding psychosocial background and treatment history
during childhood (background in the childhood family;
psychiatric disorder and/or substance abuse in one or
both parents; possible compulsory care during childhood
and/or adolescence; educational support in primary
school) and during adulthood (educational level; work
experience; previous adult psychiatric care; previous im-
prisonment). Moreover, the ADHD/SUD group was
compared with the SUD group regarding the preferred
abuse substance and self-reported psychiatric symptoms.
The ADHD/SUD group was compared with the
ADHD/Psych group regarding retrospective ADHD
symptom reports during childhood, cognition, and co-
morbidity with additional neurodevelopmental disorders.
For retrospective assessment of childhood symptoms ofADHD, the Wender Utah Rating Scale (WURS) [12] was
used. The WURS is a 61-item self-rating scale scored
on a 5-point Likert scale, from 0 = not at all or slightly
to 4 = very much. The WURS-25 includes twenty-five
items (total score 0–100) that discriminate best between
ADHD and controls. A cut-off score of 46 identifies 86%
true positives and 99% true negatives of ADHD according
to the instrument developers [12].
The general intellectual level (Full Scale IQ, FSIQ) was
measured using the Wechsler Adult Intelligence Scale
III (WAIS III) [13]. In addition to the FSIQ, the results
of the WAIS-III can be divided into Verbal IQ (VIQ)
and non-verbal or Performance IQ (PIQ). Moreover,
data can be described on the level of four indexes: the
Verbal Comprehensive Index (related to Verbal IQ) and
the Perceptual Organization Index (related to the non-
verbal IQ), as well as the two indexes loading on execu-
tive functions (EFs): the Working Memory Index and
the Processing Speed Index [13].
Statistical analyses
The group comparisons were made using the Chi-square
test for categorical variables and Student’s t-test for con-
tinuous variables. In the t-tests, the degrees of freedom
were corrected for unequal variance if indicated by
Levene’s test for equality of variance. Effect sizes for t-
tests were expressed as Cohen’s d [14] and interpreted
as effect sizes of 0.2 to 0.3, a ‘small’ effect, around 0.5
(half an SD), a ‘medium’ effect, and ≥ 0.8, a ‘large’ effect.
Effect sizes for Chi-square tests were expressed as Φ
(Phi) and interpreted as a weak association (.10–.20), a
moderate association (.20–.40), a relatively strong associ-
ation (.40–.60), a strong association (.60–.80), or a very
strong association (>.80).
In order to investigate whether the observed differ-
ences in WAIS indexes loading on EF were specific or
explained by the general intellectual ability (FSIQ), we
performed analyses of co-variance with the EF index as a
dependent variable, with group (ADHD/SUD versus
ADHD/Psych) as fixed factor while entering FSIQ as a
co-variate. The alpha-level was set at .05, while .05 ≥ p-
values ≥ .10 were regarded as statistical trends. The stat-
istical analysis was performed using the SPSS statistical
software package (IBM, SPSS™, version 20).
Results
The flowchart describes the enrolment of participants in
the ADHD/SUD group from the SiS Institution Hornö.
Out of the 413 unique cases during 2004 and 2008, as-
sessments of ADHD were made in 71 patients.
Regarding family background, educational and voca-
tional history, treatment history, psychiatric symptoms,
and the primary abused substance, the ADHD/SUD
group (n = 60) was compared with the general SUD
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year of admission to compulsory care due to SUD.
1. Family background, education, and vocation history
The statistics from the analyses of the family background,
education and vocation history are shown in Table 1.
The ADHD/SUD group exhibited a trend towards a
higher percentage of unstable family backgrounds com-
pared to the general SUD group (p = .10). Separations in
parents before seven years were more than twice as com-
mon in the ADHD/SUD group (27.7% versus 11.7%).
Psychiatric disorder and/or abuse in one or both par-
ents were common in both groups (53.3% in the ADHD/
SUD group and 56.7% in the general SUD group).
The educational level was low in both groups. In the
ADHD/SUD group, 56.7% had completed the nine-year
primary school and in the general SUD group, 48.3%.
The ADHD/SUD group showed a statistical trend towards
less work experience than the general SUD group (p= .10).
2. Previous interventions and psychiatric care
The statistics from the analyses of previous treatment
intervention and psychiatric care are shown in Table 2.
No data on special education in primary school in the
general SUD group were available. In the ADHD group,Table 1 Family background, education, and work experience




Parents separated before 7 years old 16 (26.7)
Parents separated between ages 7 and 18 12 (20%)
Single parent 11 (18.3)
Other custodian than biological parents 4 (6.7)
Both parents 17 (28.3%)
Missing data 0
Psychiatric disorder and/or abuse in parents
Psychiatric disorder and/ or abuse in parents 32 (53.4%)
No psychiatric disorder and/or abuse in parents 26 (43.3%)
Missing data 2 (3.3%)
Educational level
Less than 9 years 12 (20.0%)
Nine years 34 (56.7%)
Secondary school/ vocational education 14 (23.3%)
University/high school 0
Work experience
Work experience≤ 6 months 26 (43.3%)
Work experience > 6 months 30 (50.0%)
Missing data 4 (6.7%)the percentage of individuals who had received special
educational support in primary school was 36.7%. Second-
ary school or vocational education was slightly more fre-
quent in the general SUD group, 30.0%, compared to
23.3% in the ADHD/SUD group. The ADHD/SUD group
had a significantly higher degree of compulsory care dur-
ing childhood (LVU) than the general SUD group
(p = .040). No data on the causes of compulsory care during
childhood were available for the general SUD group, but in
the ADHD/SUD group, the most dominant cause was early
onset of substance abuse and antisocial behaviour.
Imprisonment was significantly more frequent in the
ADHD/SUD group (68.0%), compared to the general
SUD group (39.1%) (χ 2 = 15.84, p < .001).
A small difference, approaching a statistical trend
(p = .12), could be seen between the ADHD/SUD and
the general SUD groups in previous experiences of psy-
chiatric care (66.7% in the ADHD/SUD group versus
54.2% in the general SUD group).
3. Psychiatric symptoms and primary substance abuse
The statistics from the analyses of psychiatric symptoms
and primary substance abuse are shown in Table 3.
The presence of self-reported symptoms of depression
and anxiety was similar in both groups (85.0% versusin the two groups in compulsory care due to substance
known ADHD
General SUD

















2.7 0.10 .1279 (65.9%)
1 (0.8%)
Table 2 Previous interventions and psychiatric care in the two groups in compulsory care due to substance abuse:
ADHD/SUD group and the general SUD group without known ADHD
ADHD/SUD General SUD
n = 60 n = 120 χ2 p Φ
Special education in primary school
Special education in primary school 22 (36.7%) N/A
N/A N/A N/ANo special education 36 (60%) N/A
Missing data 2 (3.3%) N/A
Compulsory care during childhood (LVU)
LVU 26 (43.3%) 34 (28.4%)
4.24 .04 .15Not LVU 33 (55.0%) 85 (70.8%)
Missing data 1 (1.7%) 1 (0.8%)
Previous imprisonment
Imprisonment 41 (68.3%) 47 (39.2%)
15.8 <.001 .30
No imprisonment 16 (26.7%) 71 (59.1%)
Missing data 3 (5.0%) 2 (1.7%)
Previous adult psychiatric care
Psychiatric care in adulthood 40 (66.7%) 65 (54.2%)
2.50 .12 .12No psychiatric care in adulthood 18 (30.0%) 50 (41.6%)
Missing data 2 (3.3%) 5 (4.2%)
Note: N/A not assessed in general SUD group.
Note: P-values printed in bold indicate a statistically significant difference.
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cluding drug-induced psychotic symptoms), were re-
ported by 58.3% in the ADHD/SUD group and 64.2% in
the general SUD group (ns).
A statistically significant difference was found in pre-
ferred substance abuse (p = .049). In the ADHD/SUD
group, the stimulant drugs amphetamines and cocaine
were preferred in 53.3%, compared with 30.8% in the
general SUD group. A difference was also found in alco-
hol and benzodiazepine abuse: 6.7% and 3.3%, respect-
ively, in the ADHD/SUD group reported these drugs as
primary ones, while the percentages in the general SUD
group were 21.7% and 9.0%. Only minor differences
were found in abuse of other drugs. No data on drug
screening at admission were available in the general
SUD group, but drug screening data for the ADHD/SUD
group showed that poly-drug abuse was common.
4. Retrospective report of ADHD symptoms during
childhood and current cognitive ability
Retrospective self-ratings of ADHD symptoms during
childhood and cognitive functions in the ADHD/SUD
group (n = 60) were compared with those of the group
of men with ADHD from an outpatient psychiatric set-
ting (ADHD/Psych group, n = 107).
ADHD symptoms during childhood
Participants in the ADHD/SUD group reported signifi-
cantly more ADHD symptoms in childhood as measuredwith WURS-25 (M = 60.15, SD = 17.27) compared to the
ADHD/Psych group (M = 49.09, SD = 19.25) (t [120] =
3.21, p = .002, Cohen’s d = .62).
Cognition
Figure 2 shows the means values (+/− 1 SD) for mea-
sures of cognitive capacity in the ADHD/SUD group
and the ADHD/Psych group.
Compared to the ADHD/Psych group, the ADHD/
SUD group was found to have significantly poorer re-
sults in the full-scale IQ (n = 87, ADHD/Psych, and n =
51, ADHD/SUD, t [135.68] = 4.78, p < .001, Cohen’s
d = .79). Similarly, further analyses of verbal IQ and non-
verbal/performance IQ showed poorer results for the
ADHD/SUD group: verbal IQ (n = 86, ADHD/Psych,
and n = 51, ADHD/SUD, t [134.58] = 4.62, p = < .001,
Cohen’s d = .77), non-verbal/performance IQ (n = 86,
ADHD/Psych, and n = 51, ADHD/SUD, t [129.96] = 3.54,
p = .001, Cohen’s d = .60). Analyses on the level of the
four indexes of the WAIS-III showed similar pattern of
results, i.e. the ADHD/SUD group performed poorer in
all indexes: verbal comprehension index, VCI (n = 86,
ADHD/Psych, and n = 51, ADHD/SUD, t [135.00] = 4.20,
p < .001, Cohen’s d = .70); perceptual organization index,
POI (n = 84, ADHD/Psych, and n = 51, ADHD/SUD,
t [127.60] = 3.70, p < .001, Cohen’s d = .63); working
memory index, WMI (n = 83, ADHD/Psych, and
n = 51, ADHD/SUD, t [122.16] = 2.29, p = .129, Cohen’s
d = .40); processing speed index, PSI (n = 84, ADHD/
Table 3 Psychiatric symptoms and primary substance abuse in the two groups in compulsory care due to substance
abuse: ADHD/SUD group and the general SUD group without known ADHD
ADHD/SUD General SUD
n = 60 n = 120 χ2 p Φ
Self-reported hallucinations and other psychotic symptoms
Hallucinations and other symptoms of psychosis 35 (58.4%) 77 (64.1%)
.04 .84 .02No hallucinations or other symptoms of psychosis 20 (33.3%) 41 (34.2%)
Missing 5 (8.3%) 2 (1.7%)
Self-reported symptoms of depression and anxiety
Symptoms of depression/anxiety 51 (85.0%) 101 (84.2%)
.69 .41 .06No symptoms of depression/anxiety 6 (10.0%) 18 (15.0%)
Missing data 3 (5.0%) 1 (0.8%)
Preferred abused substance
Heroin 12 (20.0%) 25 (20.8%)
18.3 .049 .32
Amphetamine 29 (48.3%) 36 (30.0%)
Cocaine 3 (5.0%) 1 (0.8%)
Alcohol 4 (6.7%) 26 (21.7%)
Hashish/marijuana 7 (11.7%) 11 (9.2%)
GHB 3 (5.0%) 3 (2.5%)
Benzodiazepines 2 (3.3%) 9 (7.5%)
Opiates other than heroin, including analgesics 0 3 (2.5%)
Solvents 0 3 (2.5%)
Other drugs 0 2 (1.7%)
Missing data 0 1 (0.8%)
Abuse according to drug screening (not alcohol)
Benzodiazepines 35 (58.3%) N/A
Hashish/marijuana 29 (48.3%) N/A
Amphetamine 33 (55.0%) N/A
Opiates/Substitution drugs 17 (28.3%) N/A N/A N/A N/A
LSD/GHB/Ecstasy 6 (10.0%) N/A
Missing data due to detoxification before admission 10 (16.7%) N/A
Mean of drugs in positive screening test results (excluding alcohol) 2.72 N/A
Note: N/A not assessed in general SUD group.
Note: P-values printed in bold indicate a statistically significant difference.
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p = .002 , Cohen’s d = .60). On controlling for FSIQ in an
ANCOVA, the group differences in the working memory
index (WMI) and speed of processing index (PSI) no lon-
ger reached statistical significance (both p-values > .10), in-
dicating that there was no specific effect on EF in the
ADHD/SUD group.
Discussions
To the best of our knowledge, this is the first study char-
acterizing adult males with ADHD and severe SUD in
compulsory care. When compared with a general SUD
group in compulsory care without a known ADHD diag-
nosis, the ADHD/SUD group was characterized by earlyand persistent antisocial behaviours and different abuse
patterns. When compared with an outpatient group of
males with ADHD (ADHD/Psych group), the ADHD/
SUD group showed a more severe childhood symptom-
atology and poorer general cognitive ability.
Parental divorce and other unfavourable growing-up
conditions, such as substance abuse and psychiatric dis-
orders in parents, were common in both the ADHD/
SUD group and the general SUD group. However, early
separation of parents was more than twice as frequent in
the ADHD/SUD group. Adverse life events during child-
hood, such as parental psychiatric disorders and sub-
stance abuse, have previously been reported in both
individuals with ADHD [7,8,15] and individuals with
Figure 2 Cognitive ability in the ADHD/SUD group (n = 51,
missing data n = 9) and the ADHD/out-patients group (n = 87,
missing data n = 20).
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ings in the present study are in line with these reports.
Both the ADHD/SUD group and the general SUD
group had a low educational level and the two groups
did not differ largely from each other. However, the
ADHD/SUD group had been subjected to a significantly
higher degree to compulsory care (LVU) in childhood,
which always includes a compulsory 9-year primary
school education. In addition to the individuals being
subjected to compulsory care during childhood, 37.7% of
the ADHD/SUD group had received special education in
primary school. Thus, in total, 80% of the ADHD/SUD
group had received support to cope with school de-
mands. Remarkably, only 13 of the 60 individuals in the
ADHD/SUD group (21.7%) had a previous ADHD diag-
nosis at admission to SiS Institution Hornö.
Large proportions of both the ADHD/SUD group and
the general SUD group had limited work experience,
which was to be expected, bearing in mind the severe
substance use disorder in both groups. However, we also
observed a statistical trend in the ADHD/SUD group in-
cluding several individuals with less than six months of
work experience.
Antisocial behaviour was a distinguishing characteris-
tic of the ADHD/SUD group, which not only had been
subjected to a higher degree of compulsory care in child-
hood, but also imprisonment during adulthood, as com-
pared to the general SUD group in compulsory care.
The frequent co-existence of ADHD and conduct dis-
order (CD), oppositional defiant disorder (ODD), and
adult antisocial behaviour has been reported previously[19-22] and it has also been suggested that it is the com-
bination of ADHD and aggressive behaviour and/or CD
during childhood that contributes to the most increased
risk for later antisocial behaviour rather than ADHD as
such [23-26]. Furthermore, the combination of ADHD
and conduct problems during childhood has been sug-
gested to be regarded as a distinct disorder, correspond-
ing to the ICD-10 distinction between hyperkinetic
disorder and hyperkinetic CD [23,26] and, with this dis-
tinction, it seems that many in the ADHD/SUD group in
the current study would fall into the latter category.
Torok et al. (2012) also found that CD is the strongest
predictor for developing severe drug abuse, defined as
‘early onset, greater poly-drug use and more frequent
stimulant use’, (and to be distinguished from less severe
drug abuse) while ADHD without CD does not entail an
increased risk for more severity of substance abuse [27].
Taken together, the ADHD/SUD group in the current
study showed characteristics typical for both early anti-
social development and the development of severe drug
abuse [27-32].
Psychiatric co-morbidity is common in adults with
ADHD [8,15,33-35], as well as in adults with SUD with-
out ADHD [36-39]. In the current study, psychiatric
symptoms were common in both the ADHD/SUD group
and the general SUD group and the findings indicate
that externalizing and antisocial behaviour, rather than
psychiatric symptoms, are more distinctive for the
ADHD/SUD group than for the general SUD group.
In a study of longer-term prison inmates with ADHD,
all of whom had a diagnosis of substance abuse disorder,
more than 70% preferred psycho-stimulants [3]. It has
also been found that frequent stimulant use was more
common in severe drug abuse than in less severe drug
abuse, which, in turn, was found to be associated with
CD [27]. In the current study, 53.3% in the ADHD/SUD
group preferred amphetamine and cocaine, compared to
30.8% in the general SUD group. An additional differ-
ence between the groups was that the general SUD
group preferred alcohol and benzodiazepines about three
times more than the ADHD/SUD group. However, it
should be noted that this variable described self-
reported drug abuse. The drug screenings showed that
poly-substance abuse was common in the ADHD/SUD
group. No drug screening data were available for the
general SUD group.
The comparison between the ADHD/SUD group and
the ADHD/Psych group indicated medium-to-large dif-
ferences in all measured parameters. The retrospective
self-rating symptoms of ADHD during childhood were
significantly higher and the estimated IQ was signifi-
cantly lower in the ADHD/SUD group than in the
ADHD/Psych group. In previous studies, IQ on a group
level has been found to be lower in ADHD individuals
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study, the mean of full-scale IQ in the ADHD/Psych
group was at the level of the general population,
whereas, in the ADHD/SUD group, the mean was in the
lower normal zone. Similar differences were found in a
previous study [3] where male long-term prison inmates
with ADHD and SUD were compared with males with
ADHD from an outpatient psychiatric clinic, i.e. the esti-
mated IQ was significantly lower in the ADHD/prison
group. Furthermore, among offenders with intellectual
disabilities, ADHD has been found to be the most fre-
quently recorded developmental disorder [42].
The negative impact of various types of substance
abuse on memory and executive functions has been re-
ported frequently [43-49] and it can be assumed that the
often early-onset, long-standing and severe abuse in the
ADHD/SUD group has had a negative impact on cogni-
tive functions, especially executive functions. However,
executive dysfunctions are known to be associated with
ADHD also without co-existing SUD and we did not ob-
serve any specific effects in tests loading on EF, but ra-
ther a general low cognitive ability in the ADHD/SUD
group.
Altogether, the findings suggest that undiagnosed
ADHD, especially in combination with antisocial behav-
iour and poor cognitive functions, constitute a high risk
for the development of an extensive clinical burden,
which, in turn, is associated with high risks, such as acci-
dents, drug overdoses, and mortality, as well as family
burdens and high care costs for society [50-52].
In many respects, the ADHD/SUD group and the gen-
eral SUD group, showed similar clinical impairments
and did not differ in socio-demographic background
which could implicate need of intensive clinical inter-
vention in both groups to reduce their burden of harm.
However, findings in the current study also indicate that
clients with ADHD in combination with SUD at a group
level differ in some essential respects, both from the
general LVM population with SUD and the ADHD/
Psych group. This may implicate different treatment
strategies concerning pharmacological and non-
pharmacological treatment of ADHD with diverse co-
morbidities. Moreover, even ADHD-specific treatments,
such as structured behaviour therapy for adults with
ADHD [53], probably need to be modified when treating
patients with complex comorbid patterns.
Limitations
The present study has some limitations that may have
had some impact on the observed results. One limitation
is that the number of undiagnosed ADHD patients in
the general SUD group was unknown. Bearing in mind
the high prevalence of ADHD in substance abusers [2],
it is plausible that some in the general SUD group hadan undiagnosed ADHD. Likewise, the true prevalence
may have also been higher at the SiS Institution Hornö
since the assessments were voluntary and conducted
only after a request from the social worker or from the
patient himself. One conclusion is that the differences
between the ADHD/SUD group and the general SUD
group may have been larger if undiagnosed ADHD in
the general SUD group could have entirely been ruled
out. Furthermore, even though we had information on
early antisocial behaviour in the ADHD/SUD group, the
lack of formal DSM CD diagnosis can be seen as a
limitation.
Conclusions
In summary, the ADHD/SUD group exhibited a sub-
stantial and complex symptomatology with severe sub-
stance abuse and lifetime psychosocial problems,
including early and persistent antisocial behaviour, as
well as psychiatric co-morbidity and poor general cogni-
tive ability. According to the findings, a clinical implica-
tion is that the total clinical burden of adults with
ADHD and co-existing SUD should be identified and
considered in treatment planning in terms of risk fac-
tors, treatment content, and the context and duration of
treatment, as well as the short and long-term treatment
goals.
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